Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (342)	1/21/2000 1:27:00 PM
From: Luke	Respond to of 743

Hi. I have a btflab question (but only a question, not a plug) Have any of you ever researched novopharm biotech (nbi .to)? Has a couple of early cancer products, but also has a generic biologics program. novopharmbiotech.ca The reason i bring it up is because the founder of Novopharm pharma (parent of novopharm bio) recently sold to TEva for about $1Billion. He owned all of novo pharm, I think, and built it from the ground up to be the biggest canadian generics co. In selling to Teva, he kept nvo.to out of the deal (see SI thread), and provided a few million in funds. What if he decides to focus on NVO.TO? Heres a tickler on generic biologics: biospace.com Thats about all I know. Havent looked really, tho. Anybody have strong opinions?